Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Reduced perioperative blood loss in children undergoing craniosynostosis surgery using prolonged tranexamic acid
Christian Fenger-Eriksen1, Alexander D'Amore Lindholm1, Sven Erik Nørholt2
1Department of Anaesthesiology, Aarhus University Hospital, Denmark.
Insights
Combined tranexamic acid (TXA) treatment significantly reduced blood loss and transfusion needs in children undergoing craniosynostosis surgery. This approach improved clot stability, offering a potential method to minimize blood loss.
Area of Science:
- Pediatric Surgery
- Anesthesiology
- Hematology
Background:
- Tranexamic acid (TXA) is known to reduce intraoperative blood loss in pediatric craniosynostosis surgery.
- Further reduction in postoperative blood loss could minimize exposure to allogeneic blood products.
Purpose of the Study:
- To investigate the efficacy of combined intraoperative and postoperative TXA in reducing postoperative blood loss in pediatric craniosynostosis surgery.
Main Methods:
- A randomized controlled trial involving 30 children undergoing craniosynostosis surgery.
- Participants received either combined intra- and postoperative TXA or a placebo.
- Primary endpoint was postoperative blood loss; secondary endpoints included total blood loss, transfusion requirements, and clot stability.
Main Results:
- TXA significantly reduced postoperative blood loss by 18 ml/kg and total blood loss from 52 ml/kg to 28 ml/kg (P<0.001).
- Transfusions of red blood cells (RBCs) and fresh frozen plasma (FFP) were significantly reduced in the TXA group.
- Clot stability, assessed by tissue plasminogen activator-stimulated clot lysis assay, was significantly higher in the TXA group (P<0.001).
Conclusions:
- Combined intra- and postoperative TXA effectively reduces both postoperative and overall blood loss in pediatric craniosynostosis surgery.
- The treatment also decreases the need for blood transfusions.
- Enhanced clot stability is a likely mechanism contributing to the observed reduction in blood loss.
Background:
Tranexamic acid (TXA) reduces intraoperative blood loss and transfusion during paediatric craniosynostosis surgery. Additional reduction of postoperative blood loss may further reduce exposure to allogeneic blood products. We studied the effect of combined intra- and postoperative TXA treatment on postoperative blood loss in children.
Methods:
Thirty children admitted for craniosynostosis surgery were randomised to combined intra- and postoperative TXA treatment or placebo. The primary endpoint was postoperative blood loss. Secondary endpoints included total blood loss, transfusion requirements, and clot stability evaluated by tissue plasminogen activator-stimulated clot lysis assay.
Results:
TXA reduced postoperative blood loss by 18 ml kg-1 (95% confidence interval 8.9) and total blood loss from a mean of 52 ml kg-1 (standard deviation [SD]; 20) ml kg-1 to 28 (14) ml kg-1 (P<0.001). Intraoperative red blood cell (RBC) and fresh frozen plasma (FFP) transfusions were reduced in the treatment group from RBC 14.0 (5.2) ml kg-1 to 8.2 (5.1) ml kg-1 (P=0.01) and from FFP 13.0 (6.3) ml kg-1 to 7.8 (5.9) ml kg-1 (P=0.03). Postoperative RBC transfusion median was 5 (inter-quartile range [IQR] 0-6) ml kg-1 in the placebo group and 0 (0-5.7) ml kg-1 in the TXA group. Resistance to lysis was higher in the treatment group (P<0.001).
Conclusions:
Combined intra- and postoperative tranexamic acid treatment reduced postoperative and overall blood loss and transfusion requirements. Improved clot stability represents a possible mechanism for blood loss reduction.
Related Concept Videos
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Adaptations that Reduce Water Loss
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview

